October 22, 2014
UNC scientists discover hidden subpopulation of melanoma cells
The research, led by Andrew C. Dudley, has implications for developing cancer drugs that target blood vessels that feed tumors.
Tag: UCRF
October 22, 2014
Meyer named faculty director of ICISS
UNC Lineberger Comprehensive Cancer Center member, Anne-Marie Meyer, PhD, assistant professor of cancer epidemiology, has been named faculty director of the Integrated Cancer Information and Surveillance System (ICISS).
October 20, 2014
DeSimone elected to all three branches of the National Academies
Dr. Joseph DeSimone, Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and UNC Lineberger member, has been elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine a U. S. scientist can receive.
October 9, 2014
New website launched to help women learn about risk factors for breast cancer
The UNC Breast Cancer and the Environment Research Program (BCERP) has announced the official launch of myBCrisk.org, an interactive website designed to increase knowledge about breast cancer risk factors, especially among young African-American women.
October 1, 2014
Komen awards more than $875,000 to UNC Lineberger researchers
Susan G. Komen® has awarded over $875,000 in research funding to UNC Lineberger Comprehensive Cancer Center.
September 26, 2014
UNC Lineberger hosts Metastatic Breast Cancer Network Conference
The Metastatic Breast Cancer Network (MBCN) held its 8th Annual National Conference in Chapel Hill September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center.
September 8, 2014
Basch contributes to new ASCO guidelines for prostate cancer treatment
New clinical guidelines have been announced for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO). Ethan Basch, MD, director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, served as the co-chair of the ASCO/CCO expert panel that developed the guideline.
September 8, 2014
UNC researchers find new genetic target for a different kind of cancer drug
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.
September 8, 2014
Popular cancer drug target implicated in cardiovascular defects
Research led by UNC’s Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development
September 4, 2014
Changing the face of clinical trials
UNC Lineberger secures three major NCI grants to advance the nation’s clinical trials program.